Written Question·Department of Health and Social Care·UIN 35251
Coronavirus: Vaccination
Tabled: 4 March 2025
Answered: 12 March 2025
Question
Esther McVey
Conservative — Tatton
To ask the Secretary of State for Health and Social Care, with reference to paragraph 3.7 of the minutes of the Covid-19 Vaccine Benefit Risk Expert Working Group held on 18 November 2020, if he will publish the risk-based evaluation for the Pfizer/BioNTe
Answer
Ashley DaltonThe reactogenicity of vaccines refers to their capacity to produce common or “expected” adverse reactions following vaccination such as fever, tiredness, and a sore arm at the vaccination site. These reactions, and the frequency with which they occur, are...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 35251) →